The new report by Expert Market Research titled, ‘Global Cholera Vaccines Market Report and Forecast 2022-2027’, gives an in-depth analysis of the global cholera vaccines market, assessing the market based on its segments like products, and major regions. The report tracks the latest trends in the industry and studies their impact on the overall market. It also assesses the market dynamics, covering the key demand and price indicators, along with analysing the market based on the SWOT and Porter’s Five Forces models.
Get a Free Sample Report with Table of Contents: https://www.expertmarketresearch.com/reports/cholera-vaccines-market/requestsample
The key highlights of the report include:
Market Overview (2017-2027)
- Forecast CAGR (2022-2027): 6%
Dukoral is expected to have a considerable market share in the cholera vaccines sector based on product. The fact that Dukoral is the only oral (drinkable) vaccine currently on the market that protects against cholera and diarrhoea caused by Enterotoxigenic E. coli (ETEC), the most prevalent cause of diarrhoea for travellers to many regions of the world, is driving up demand for the medication. This element is aiding in the segment’s expansion.
Adults and children aged 2 and up can also take Dukoral. Aside from that, the segment is expected to develop in the coming years due to the growing population in the cholera-endemic zone as well as the increasing number of people travelling to the region. These factors are projected to contribute to market expansion throughout the forecast period.
In the forecast year, Asia Pacific is expected to hold a significant proportion of the cholera vaccines market. The rising prevalence of cholera in the region is to blame for this increase. Additionally, rising government spending on the vaccination process is expected to drive market growth during the projection period. Furthermore, in the coming years, increased vaccine awareness and greater availability of oral vaccines in the region are likely to enhance the market growth. During the forecast period, these aspects are expected to boost overall market expansion.
Industry Definition and Major Segments
Cholera is a severe diarrhoeal sickness caused by an infection in the small intestine. It is transmitted by consuming water or food contaminated with the bacteria Vibrio cholerae. Every year, an estimated 1.3 to 4.0 million cases of cholera are reported, resulting in 21,000 to 1,43,000 fatalities globally. Cholera vaccines are critical in preventing the transmission of the disease, and the WHO recommends them for persons travelling to and living in cholera-affected areas.
Read Full Report with Table of Contents: https://www.expertmarketresearch.com/reports/cholera-vaccines-market
By product, the market is divided into:
The regional markets for the product include:
- North America
- the Asia Pacific
- Latin America
- the Middle East and Africa
Every year, an estimated 1.3 to 4.0 million cases of cholera are reported, according to WHO figures. The condition affects both children and adults and, if left untreated, can lead to death. Cholera is connected to a lack of safe drinking water and sanitation services. In this context, the WHO Global Task Force on Cholera Control (GTFCC), a programme aiming at preventing the spread of cholera by 2030, was established with the goal of reducing the disease’s mortality risk by 90% in cholera-prone areas such as Asia and Africa by 2030. As a result, cholera vaccinations are in higher demand all around the world. Furthermore, increased government investments in the development of effective cholera vaccines are expected to drive market expansion in the coming years. These factors are projected to have a positive impact on market growth in the near future.
Key Market Players
The major players in the market are Sanofi-aventis Groupe, Emergent BioSolutions Inc., Valneva SE, GlaxoSmithKline plc., Intervet Inc. and EuBiologics Co., Ltd. The report covers the market shares, capacities, plant turnarounds, expansions, investments and mergers and acquisitions, among other latest developments of these market players.
Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company’s expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.
EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over a 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.
Company Name: EMR Inc.
Contact Person:- Ian Bell, Business Consultant
Toll Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, US
Country: United States
Explore more on Procurement Intelligence services of EMR Inc.
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.